Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011641

« Back to Dashboard

NDA 011641 describes DIABINESE, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the DIABINESE profile page.

The generic ingredient in DIABINESE is chlorpropamide. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpropamide profile page.

Summary for 011641

Tradename:	DIABINESE
Applicant:	Pfizer
Ingredient:	chlorpropamide
Patents:	0
Therapeutic Class:	Blood Glucose Regulators
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 011641

Hypoglycemic Agents

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	100MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 006

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	250MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice

Harvard Business School

Cerilliant

Johnson and Johnson

Accenture

Julphar

QuintilesIMS

McKinsey

Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.